Biomarkers of COVID-19 severity may not serve patients with polycystic ovary syndrome
- PMID: 33573655
- PMCID: PMC7876982
- DOI: 10.1186/s12967-021-02723-7
Biomarkers of COVID-19 severity may not serve patients with polycystic ovary syndrome
Keywords: Biomarkers; COVID-19; Coagulation factors; Platelet degranulation; Polycystic ovary syndrome; SARS-CoV-2.
Conflict of interest statement
No authors have any conflict of interest or competing interests to declare.
Figures

Comment on
-
Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19.Immunity. 2020 Nov 17;53(5):1108-1122.e5. doi: 10.1016/j.immuni.2020.10.008. Epub 2020 Oct 20. Immunity. 2020. PMID: 33128875 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical